Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Raw Materials (2016 - 2025)

InspireMD filings provide 14 years of Raw Materials readings, the most recent being $2.1 million for Q4 2025.

  • On a quarterly basis, Raw Materials rose 10.45% to $2.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 million, a 10.45% increase, with the full-year FY2025 number at $2.1 million, up 10.45% from a year prior.
  • Raw Materials hit $2.1 million in Q4 2025 for InspireMD, down from $2.3 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $2.3 million in Q3 2025 to a low of $581000.0 in Q3 2021.
  • Median Raw Materials over the past 5 years was $999000.0 (2023), compared with a mean of $1.3 million.
  • Biggest five-year swings in Raw Materials: fell 26.64% in 2021 and later soared 78.26% in 2024.
  • InspireMD's Raw Materials stood at $615000.0 in 2021, then skyrocketed by 51.54% to $932000.0 in 2022, then soared by 43.13% to $1.3 million in 2023, then surged by 43.48% to $1.9 million in 2024, then increased by 10.45% to $2.1 million in 2025.
  • The last three reported values for Raw Materials were $2.1 million (Q4 2025), $2.3 million (Q3 2025), and $2.2 million (Q2 2025) per Business Quant data.